Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]

Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, s...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Gao J [verfasserIn] Zhang Z [verfasserIn] Su H [verfasserIn] Zong L [verfasserIn] Li Y [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2021

Schlagwörter:	esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383

Übergeordnetes Werk:	In: Cancer Management and Research - Dove Medical Press, 2009, (2021), Seite 7491-7492
Übergeordnetes Werk:	year:2021 ; pages:7491-7492

Links:	Link aufrufen Link aufrufen Journal toc

Katalog-ID:	DOAJ052963373

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ052963373
003	DE-627
005	20230308171727.0
007	cr uuu---uuuuu
008	230227s2021 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)DOAJ052963373
035			\|a (DE-599)DOAJdf69540129c94a1993132c7b97ce265c
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC254-282
100	0		\|a Gao J \|e verfasserin \|4 aut
245	1	0	\|a Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
650		4	\|a esophageal squamous cell carcinoma
650		4	\|a fgd5 antisense rna 1
650		4	\|a microrna-383
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a Zhang Z \|e verfasserin \|4 aut
700	0		\|a Su H \|e verfasserin \|4 aut
700	0		\|a Zong L \|e verfasserin \|4 aut
700	0		\|a Li Y \|e verfasserin \|4 aut
773	0	8	\|i In \|t Cancer Management and Research \|d Dove Medical Press, 2009 \|g (2021), Seite 7491-7492 \|w (DE-627)606030840 \|w (DE-600)2508013-1 \|x 11791322 \|7 nnns
773	1	8	\|g year:2021 \|g pages:7491-7492
856	4	0	\|u https://doaj.org/article/df69540129c94a1993132c7b97ce265c \|z kostenfrei
856	4	0	\|u https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1179-1322 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|j 2021 \|h 7491-7492

Indexfelder

author_variant	g j gj z z zz s h sh z l zl l y ly
matchkey_str	article:11791322:2021----::ogocdnrag5sataaoptnedgnuranirra8tehnehmlgathrceitcoeohgasumuclc
hierarchy_sort_str	2021
callnumber-subject-code	RC
publishDate	2021
allfields	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c DE-627 ger DE-627 rakwb eng RC254-282 Gao J verfasserin aut Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Zhang Z verfasserin aut Su H verfasserin aut Zong L verfasserin aut Li Y verfasserin aut In Cancer Management and Research Dove Medical Press, 2009 (2021), Seite 7491-7492 (DE-627)606030840 (DE-600)2508013-1 11791322 nnns year:2021 pages:7491-7492 https://doaj.org/article/df69540129c94a1993132c7b97ce265c kostenfrei https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR kostenfrei https://doaj.org/toc/1179-1322 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2021 7491-7492
spelling	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c DE-627 ger DE-627 rakwb eng RC254-282 Gao J verfasserin aut Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Zhang Z verfasserin aut Su H verfasserin aut Zong L verfasserin aut Li Y verfasserin aut In Cancer Management and Research Dove Medical Press, 2009 (2021), Seite 7491-7492 (DE-627)606030840 (DE-600)2508013-1 11791322 nnns year:2021 pages:7491-7492 https://doaj.org/article/df69540129c94a1993132c7b97ce265c kostenfrei https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR kostenfrei https://doaj.org/toc/1179-1322 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2021 7491-7492
allfields_unstemmed	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c DE-627 ger DE-627 rakwb eng RC254-282 Gao J verfasserin aut Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Zhang Z verfasserin aut Su H verfasserin aut Zong L verfasserin aut Li Y verfasserin aut In Cancer Management and Research Dove Medical Press, 2009 (2021), Seite 7491-7492 (DE-627)606030840 (DE-600)2508013-1 11791322 nnns year:2021 pages:7491-7492 https://doaj.org/article/df69540129c94a1993132c7b97ce265c kostenfrei https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR kostenfrei https://doaj.org/toc/1179-1322 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2021 7491-7492
allfieldsGer	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c DE-627 ger DE-627 rakwb eng RC254-282 Gao J verfasserin aut Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Zhang Z verfasserin aut Su H verfasserin aut Zong L verfasserin aut Li Y verfasserin aut In Cancer Management and Research Dove Medical Press, 2009 (2021), Seite 7491-7492 (DE-627)606030840 (DE-600)2508013-1 11791322 nnns year:2021 pages:7491-7492 https://doaj.org/article/df69540129c94a1993132c7b97ce265c kostenfrei https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR kostenfrei https://doaj.org/toc/1179-1322 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2021 7491-7492
allfieldsSound	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c DE-627 ger DE-627 rakwb eng RC254-282 Gao J verfasserin aut Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Zhang Z verfasserin aut Su H verfasserin aut Zong L verfasserin aut Li Y verfasserin aut In Cancer Management and Research Dove Medical Press, 2009 (2021), Seite 7491-7492 (DE-627)606030840 (DE-600)2508013-1 11791322 nnns year:2021 pages:7491-7492 https://doaj.org/article/df69540129c94a1993132c7b97ce265c kostenfrei https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR kostenfrei https://doaj.org/toc/1179-1322 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2021 7491-7492
language	English
source	In Cancer Management and Research (2021), Seite 7491-7492 year:2021 pages:7491-7492
sourceStr	In Cancer Management and Research (2021), Seite 7491-7492 year:2021 pages:7491-7492
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	Cancer Management and Research
authorswithroles_txt_mv	Gao J @@aut@@ Zhang Z @@aut@@ Su H @@aut@@ Zong L @@aut@@ Li Y @@aut@@
publishDateDaySort_date	2021-01-01T00:00:00Z
hierarchy_top_id	606030840
id	DOAJ052963373
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ052963373</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308171727.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ052963373</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJdf69540129c94a1993132c7b97ce265c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Gao J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265&ndash;2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as &ldquo;Retracted&rdquo;. This retraction relates to this paper</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">esophageal squamous cell carcinoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fgd5 antisense rna 1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microrna-383</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Z</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Su H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zong L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cancer Management and Research</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2021), Seite 7491-7492</subfield><subfield code="w">(DE-627)606030840</subfield><subfield code="w">(DE-600)2508013-1</subfield><subfield code="x">11791322</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2021</subfield><subfield code="g">pages:7491-7492</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/df69540129c94a1993132c7b97ce265c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-1322</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2021</subfield><subfield code="h">7491-7492</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Gao J
spellingShingle	Gao J misc RC254-282 misc esophageal squamous cell carcinoma misc fgd5 antisense rna 1 misc microrna-383 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
authorStr	Gao J
ppnlink_with_tag_str_mv	@@773@@(DE-627)606030840
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC254-282
illustrated	Not Illustrated
issn	11791322
topic_title	RC254-282 Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction] esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383
topic	misc RC254-282 misc esophageal squamous cell carcinoma misc fgd5 antisense rna 1 misc microrna-383 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RC254-282 misc esophageal squamous cell carcinoma misc fgd5 antisense rna 1 misc microrna-383 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RC254-282 misc esophageal squamous cell carcinoma misc fgd5 antisense rna 1 misc microrna-383 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Cancer Management and Research
hierarchy_parent_id	606030840
hierarchy_top_title	Cancer Management and Research
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)606030840 (DE-600)2508013-1
title	Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
ctrlnum	(DE-627)DOAJ052963373 (DE-599)DOAJdf69540129c94a1993132c7b97ce265c
title_full	Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
author_sort	Gao J
journal	Cancer Management and Research
journalStr	Cancer Management and Research
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2021
contenttype_str_mv	txt
container_start_page	7491
author_browse	Gao J Zhang Z Su H Zong L Li Y
class	RC254-282
format_se	Elektronische Aufsätze
author-letter	Gao J
author2-role	verfasserin
title_sort	long noncoding rna fgd5-as1 acts as a competing endogenous rna on microrna-383 to enhance the malignant characteristics of esophageal squamous cell carcinoma by increasing sp1 expression [retraction]
callnumber	RC254-282
title_auth	Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
abstract	Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
abstractGer	Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
abstract_unstemmed	Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265–2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
title_short	Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]
url	https://doaj.org/article/df69540129c94a1993132c7b97ce265c https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR https://doaj.org/toc/1179-1322
remote_bool	true
author2	Zhang Z Su H Zong L Li Y
author2Str	Zhang Z Su H Zong L Li Y
ppnlink	606030840
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
callnumber-a	RC254-282
up_date	2024-07-03T15:01:59.579Z
_version_	1803570558620663808
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ052963373</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308171727.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ052963373</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJdf69540129c94a1993132c7b97ce265c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Gao J</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gao J, Zhang Z, Su H, Zong L, Li Y. Cancer Manag Res. 2020;12:2265&ndash;2278. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 5B and 7B with similar images from unrelated articles, specifically: Figure 5B, panel Eca109 si-FGD5-AS1+antagomir-NC appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 7B appears to have been duplicated with similar images from Figure 7b in Bi et al, 2020 (https://doi.org/10.1080/15384101.2020.1731645). The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as &ldquo;Retracted&rdquo;. This retraction relates to this paper</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">esophageal squamous cell carcinoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fgd5 antisense rna 1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microrna-383</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhang Z</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Su H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zong L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cancer Management and Research</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2021), Seite 7491-7492</subfield><subfield code="w">(DE-627)606030840</subfield><subfield code="w">(DE-600)2508013-1</subfield><subfield code="x">11791322</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2021</subfield><subfield code="g">pages:7491-7492</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/df69540129c94a1993132c7b97ce265c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/retraction-long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous--peer-reviewed-fulltext-article-CMAR</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1179-1322</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2021</subfield><subfield code="h">7491-7492</subfield></datafield></record></collection>
score	7.401044

Nicht das Richtige dabei?

Schreiben Sie uns!

Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression [Retraction]

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?